*  Plus it
Vehicle, erlotinib (50 mg/kg/d, orally), pertuzumab (12 mg/kg loading dose, then 6 mg/kg i.p. once weekly), or erlotinib with ... Cell lines and culture conditions. Chugai Pharmaceuticals, Co., Ltd. (Kamakura, Kanagawa, Japan) supplied the NSCLC cell lines ... Vehicle, erlotinib (50 mg/kg/d, orally), pertuzumab (12 mg/kg loading dose, then 6 mg/kg i.p. once weekly), or erlotinib with ... Vehicle, erlotinib (50 mg/kg/d, orally), pertuzumab (12 mg/kg loading dose, then 6 mg/kg i.p. once weekly), or erlotinib with ...
  http://clincancerres.aacrjournals.org/content/11/14/5300
*  How self-driving cars might impact auto insurance | Rosenthal & Kreeger LLP
Google has been testing its autonomous vehicles on California roads. While some people believe that the mass adoption of the ... Our client was riding his motorcycle when the driver of a vehicle pulled out from a stop sign directly in his path. Our client ... 1.253 Million Product Liability - Pharmaceutical. Evidence developed by American Home Products Corporation in the litigation ... Rosenthal obtained a settlement for a passenger in a vehicle being driven by a drunk driver that ran off a wet roadway at 90 ...
  https://www.rosenthalkreeger.com/blog/2016/05/how-self-driving-cars-might-impact-auto-insurance.shtml
*  RCSB PDB - Ligand Summary Page
Pharmaceutical Preparations. *Pharmaceutical Vehicles. *Propylene Glycols. *Solvents. *Specialty Uses of Chemicals. * ... A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations. [PubChem] ...
  http://www.rcsb.org/pdb/ligand/ligandsummary.do?handler=biologyChemistry&hetId=PGR
*  Patent US4708834 - Preparation of gelatin-encapsulated controlled release composition - Google Patents
A controlled-release pharmaceutical unit dosage form is provided comprising a gelatin capsule enclosing a solid matrix formed ... Pharmaceutical vehicle. US4391909 *. May 1, 1981. Jul 5, 1983. Damon Corporation. Microcapsules containing viable tissue cells ... Pharmaceutical dosage unit for rectal administration. US5505959 *. Mar 31, 1994. Apr 9, 1996. Nestec S.A.. Pharmaceutical ... Soft gelatin pharmaceutical dosage form. US5919481 *. Jun 28, 1996. Jul 6, 1999. Ncneil-Ppc, Inc.. Fill material for soft ...
  http://www.google.com/patents/US4708834?dq=5572193
*  Patent US4843112 - Bioerodable implant composition - Google Patents
Pharmaceutical vehicle. US4346709 *. Nov 10, 1980. Aug 31, 1982. Alza Corporation. Drug delivery devices comprising erodible ... Key Pharmaceuticals, Inc.. Polymeric diffusion matrix containing a vasodilator. US4293539 *. Sep 12, 1979. Oct 6, 1981. Eli ... Sustained release of pharmaceuticals from polyester matrices. US3982537 *. Dec 30, 1974. Sep 28, 1976. Louis Bucalo. Dynamic ... When a pharmaceutical agent is incorporated into the cross-linked biodegradable matrix it serves as a depot device for ...
  http://www.google.com/patents/US4843112?dq=5685792
*  Patente US4224339 - Treatment of disturbed keratinization - Google Patentes
Chemex Pharmaceuticals, Inc.. Pharmaceutical vehicles for recucing transdermal flux. WO1989008445A1 *. 15 Mar 1989. 21 Sep 1989 ...
  http://www.google.es/patents/US4224339?dq=flatulence
*  Patent US4752470 - Controlled release indomethacin - Google Patents
Sustained release type of pharmaceutical vehicles. US3081233 *. 8 Aug 1960. 12 Mar 1963. Upjohn Co. Enteric-coated pilules. ... Adare Pharmaceuticals, Inc.. Timed, pulsatile release systems. US9161919. 19 Jul 2011. 20 Oct 2015. Adare Pharmaceuticals, Inc. ... Adare Pharmaceuticals, Inc.. Timed, pulsatile release systems. US9579293. 16 Oct 2015. 28 Feb 2017. Adare Pharmaceuticals, Inc. ... Key Pharmaceuticals, Inc.. Sustained release aspirin. US4524060 *. 28 Oct 1983. 18 Jun 1985. John Wyeth & Brother Limited. Slow ...
  http://www.google.com.au/patents/US4752470
*  Patente US5976555 - Topical oil-in-water emulsions containing retinoids - Google Patentes
Foamix Pharmaceuticals Ltd.. Wax foamable vehicle and pharmaceutical compositions thereof. US9668972. 11 Mar 2005. 6 Jun 2017. ... Foamix Pharmaceuticals Ltd.. Foamable vehicle and pharmaceutical compositions thereof. US9662298. 22 Ene 2014. 30 May 2017. ... Foamix Pharmaceuticals Ltd.. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof. US9320705. 8 Ene 2009 ... Foamix Pharmaceuticals Ltd.. Penetrating pharmaceutical foam. US9539208. 4 Feb 2014. 10 Ene 2017. Foamix Pharmaceuticals Ltd.. ...
  http://www.google.es/patents/US5976555
*  CDC - The Emergency Response Safety and Health Database: Systemic Agent: ETHYLENE GLYCOL - NIOSH
... it also is used as a pharmaceutical vehicle. Ethylene glycol has a sweet taste and is often accidentally or intentionally ...
  https://www.cdc.gov/niosh/ershdb/EmergencyResponseCard_29750031.html
*  Patent US20080004564 - Controlled release membrane and methods of use - Google Patents
... thereby facilitating the administration of the active agent or pharmaceutical drug. ... In some embodiments, the one or more active agent reservoirs 34 are loadable with a vehicle and/or pharmaceutical composition ... pharmaceuticals (e.g., a drug, a therapeutic compound, pharmaceutical salts, and the like) non-pharmaceuticals (e.g., a ... In at least one embodiment, regardless of the type of pharmaceutical drug delivery vehicle used with the EAP, the EAP membrane ...
  http://www.google.ca/patents/US20080004564
*  Patente US5423739 - Device and method for iontophoretic drug delivery - Google Patentes
Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles. WO2007041526A2 *. 2 Oct 2006. ... Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles. WO2007041314A3 *. 27 Sep 2006 ... Key Pharmaceuticals, Inc.. Method and apparatus for iontophoretic drug delivery. US4731049 *. 30 Ene 1987. 15 Mar 1988. Ionics ... Yamanouchi Pharmaceutical Co., Ltd.. Plaster structural assembly for iontophoresis. US4927408 *. 3 Oct 1988. 22 May 1990. Alza ...
  http://www.google.es/patents/US5423739
*  Patente US4915685 - Methods and apparatus for iontophoresis application of medicaments at a ... - Google Patentes
Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles. US20070088331 *. 18 Ago 2006. ... Key Pharmaceuticals, Inc.. Method and apparatus for iontophoretic drug delivery. US4731049 *. 30 Ene 1987. 15 Mar 1988. Ionics ... Its use could thus become extremely significant in administering drugs and pharmaceuticals where frequent injections are ... By iontophoretic techniques, various substances (including some pharmaceuticals and medicaments) have been administered to a ...
  http://www.google.es/patents/US4915685
*  Patent US6756059 - Topical composition, topical composition precursor, and methods for ... - Google Patents
High oil phase pharmaceutical vehicles and sunscreen compositions having waterproof sun protection factors. ... High oil phase pharmaceutical vehicles and sunscreen compositions having waterproof sun protection factors. ... Kv Pharmaceutical Company. Vaginal delivery system. US5320838. Dec 21, 1992. Jun 14, 1994. Pro Cure Products, Ltd.. Protectant ... Skinvisible Pharmaceuticals, Inc.. Antifungal composition and methods for using. WO2008066618A3 *. Oct 19, 2007. Dec 18, 2008. ...
  http://www.google.com/patents/US6756059?dq=6,455,937
*  US6254893B1 - Composition for treating dry eye - Google Patents
Topical ophthalmic pharmaceutical vehicles US5041434A (en) * 1991-08-17. 1991-08-20. Virginia Lubkin. Drugs for topical ... Barnes-Hind Pharmaceuticals, Inc.. Treatment of dry eye US4409205A (en) * 1979-03-05. 1983-10-11. Cooper Laboratories, Inc.. ... Senju Pharmaceutical Co., Ltd.. Stable aqueous preparation US5290572A (en) * 1992-08-06. 1994-03-01. Deo Corporation. Opthalmic ... Senju Pharmaceutical Co., Ltd.. Stable aqueous preparation US5290572A (en) * 1992-08-06. 1994-03-01. Deo Corporation. Opthalmic ...
  https://patents.google.com/patent/US6254893
*  Preparation for control of T-system of immunity and method for producing same - Patent # 4377511 - PatentGenius
13) mixing the peptides with a pharmaceutical vehicle.. It is advisable that the salting-out in stage (8) be conducted at a ... 2. A preparation according to claim 1, wherein as the pharmaceutical vehicle a physiological solution is used.. 3. A ... A preparation comprising an effective amount of the T-system immunity active principle of claim 1 and a pharmaceutical vehicle ... In this preparation a physiological solution is used as a vehicle. The physiological solution comprises a 0.14 M solution of ...
  http://www.patentgenius.com/patent/4377511.html
*  Patent US7201929 - Aspirin formulation for cardiovascular health - Google Patents
5,698,155). Other examples of suitable pharmaceutical vehicles are described in Remington's Pharmaceutical Sciences, Alfonso R ... Such pharmaceutical vehicles can be liquids, such as water and oils, including those of petroleum, animal, vegetable or ... The pharmaceutical vehicles can be saline, gum acacia, gelatin, starch paste, talc, keratin, colloidal silica, urea, and the ... Suitable pharmaceutical vehicles also include excipients such as starch, glucose, lactose, sucrose, gelatin, malt, rice, flour ...
  http://www.google.com/patents/US7201929?dq=7,129,317
*  US4708834A - Preparation of gelatin-encapsulated controlled release composition - Google Patents
A controlled-release pharmaceutical unit dosage form is provided comprising a gelatin capsule enclosing a solid matrix formed ... Pharmaceutical vehicle US4391909A (en) * 1979-03-28. 1983-07-05. Damon Corporation. Microcapsules containing viable tissue ... Pharmaceutical dosage unit for rectal administration US6818229B1 (en) 1993-09-20. 2004-11-16. Kos Pharmaceuticals, Inc.. ... Orally administrable pharmaceutical formulation US6676967B1 (en) 1993-09-20. 2004-01-13. Kos Pharmaceuticals, Inc.. Methods for ...
  https://patents.google.com/patent/US4708834?oq=flatulence
*  Potassium Stearate | Cosmetics Info
Pharmaceutical vehicles containing 5.5% Magnesium Stearate were neither teratogenic nor mutagenic. Seven out of 20 human ...
  http://www.cosmeticsinfo.org/ingredient/potassium-stearate
*  US4416274A - Ion mobility limiting iontophoretic bioelectrode - Google Patents
Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles US5221254A (en) 1993-06-22. ... Key Pharmaceuticals, Inc.. Method and apparatus for iontophoretic drug delivery US4752285A (en) * 1986-03-19. 1988-06-21. The ... Key Pharmaceuticals, Inc.. Method and apparatus for iontophoretic drug delivery WO1988000846A1 (en) * 1986-07-25. 1988-02-11. ... Gensia Pharmaceuticals, Inc.. Apparatus and method for iontophoretic transfer US5221254A (en) * 1991-04-02. 1993-06-22. Alza ...
  https://patents.google.com/patent/US4416274?oq=flatulence
*  Brevet US20070148158 - Rationally designed heparinases derived from heparinase II - Google Brevets
In yet another embodiment the heparinase is administered in a pharmaceutical vehicle suitable for topical application. ... A pharmaceutical preparation comprising a sterile formulation of the modified heparinase II of claim 1. and a pharmaceutically ... Among the acceptable vehicles and solvents that may be employed are water, Ringer's solution, and isotonic sodium chloride ... A pharmaceutical preparation comprising a sterile formulation of any of the substantially pure heparinases encompassed by the ...
  http://www.google.fr/patents/US20070148158
*  Process for the preparation of inducers of non-specific immunity and product produced - Patent # 5094850 - PatentGenius
The inducers of non-specific immunity can also be incorporated in other pharmaceutical vehicles. In this connection, care must ... Before the lyophilizate is used it is mixed,appropriate for the starting volume, with customary pharmaceutical vehicles, ... be taken that the sterility and stability are not imparied, for example by proteolytic constituents of the vehicle.. In ...
  http://www.patentgenius.com/patent/5094850.html
*  US4744987A - Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation - Google...
The composition is useful as a pharmaceutical excipient. The coprocessed composition is prepared by forming a well-dispersed ... Pharmaceutical vehicle composition and process of producing same US4310520A (en) * 1977-07-30. 1982-01-12. Mikasa Chemical ... Pharmaceutical vehicle composition and process of producing same US4452722A (en) * 1980-10-31. 1984-06-05. International ... Pharmaceutical compositions comprising fluvastatin US20100303919A1 (en) * 2001-04-11. 2010-12-02. Oskar Kalb. Pharmaceutical ...
  https://patents.google.com/patent/US4744987?oq=flatulence
*  US20020001652A1 - Process for making granulated N-[N- (3, 3-dimethylbutyl) -L-alpha -aspartyl] -L- phenylalanine 1-methyl ester...
Pharmaceutical vehicle composition and process of producing same US5582351A (en) 1996-12-10. Convenient to use aspartame and ... Pharmaceutical Composition with High-Potency Sweetener US20070134391A1 (en) * 2005-11-23. 2007-06-14. The Coca-Cola Company. ... Pharmaceutical Composition with High-Potency Sweetener US20070134391A1 (en) * 2005-11-23. 2007-06-14. The Coca-Cola Company. ... Direct compression vehicles and method therefor US4619833A (en) 1986-10-28. Process for producing a rapidly water-soluble, free ...
  https://patents.google.com/patent/US20020001652?oq=2%2C726%2C156%2C
*  Patent US3882036 - Contact lens cleaning and storing composition including nonionic surfactant ... - Google Patents
Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to ... Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to ... Ophthalmological preparations and vehicles and method of making the same. US2921885 *. Nov 25, 1955. Jan 19, 1960. Colgate ... Flow Pharmaceuticals, Inc.. Contact lens cleaning composition. US4065324 *. Dec 16, 1976. Dec 27, 1977. Burton, Parsons And ...
  http://www.google.com/patents/US3882036?dq=6,064,942
*  Patent US6448225 - Human growth hormone aqueous formulation - Google Patents
Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to ... Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to ... Pharmaceutical formulation. US8900577. Sep 6, 2012. Dec 2, 2014. Biogen Idec Ma Inc.. Immunoglobulin formulation and method of ... Elan Pharmaceuticals, Inc.. Immunoglobulin formulation and method of preparation thereof. US20100029569 *. Oct 8, 2009. Feb 4, ...
  http://www.google.com/patents/US6448225?dq=5166694